Summary
Outbreaks of hepatitis have occurred in renal units all over Europe and the U.S.A. and have carried a high mortality. This is an iatrogenic disease, transmitted by blood from carriers of SH virus, uraemic patients often suffering subclinical attacks.
The risks to the staff of these units are so high that they should not be asked to undertake this work if outbreaks cannot be controlled.
OUTBREAKS of hepatitis have occurred in many haemodialysis and transplantation units in this country. Similar outbreaks have occurred in Europe and the United States. In many cases these outbreaks have been large and there has been a significant mortality, especially among the staff. There can therefore be no doubt that haemodialysis-associated hepatitis is a real clinical entity. As it has occurred following the introduction of haemodialysis it can be classified as an iatrogenic disease, and it is certainly the most important iatrogenic disease that we have yet produced. take the extreme view that we must learn to prevent these outbreaks, otherwise it will become unethical to expose healthy young staff to these risks, and haemodialysis and transplantation facilities will have to be seriously restricted. If this position be accepted, then the future of haemodialysis and renal transplantation will depend on our ability to control these outbreaks.
Prevention of further outbreaks
Fortunately I think we now have the knowledge to prevent these outbreaks. The key advance has been the clinical application of the SH antigen test as most of the serious outbreaks have been due to serum hepatitis (MS-2) (Turner & Bruce White, 1969) . Outbreaks of infective hepatitis (MS-1) occur, but they do not appear to be as serious and tend to be of short duration. All patients must be SH screened before admission to dialysis and transplantation units. The SH virus usually enters the dialysis unit by means of blood transfusion, and the amount of blood transfused must be seriously curtailed. Blood transfusion cannot be avoided completely, but when essential the blood should be screened for SH antigen. The other safeguard is only to use blood from donors who have given at least five previous donations without trouble. Because of the long incubation period infection has usually spread to other patients before it is noted that a member of staff is infected. It has, therefore, usually been found that there are several SH carriers on infected units, and this makes the task of controlling the epidemic much more difficult. The large hospital-based dialysis units are therefore highly dangerous and they should be replaced by smaller four-bedded units concentrating on home dialysis training and the holding of small transplant pools. This is an important step, and it is to be hoped that the Department of Health will revise its policy concerning the ideal size of a dialysis unit. If these measures are strictly observed, I think that future outbreaks can be largely prevented, and it need hardly be stressed that prevention is the only logical policy to adopt.
Theoretical considerations
There are several interesting theoretical aspects of these outbreaks. It Antigens presented to the spleen induce antibody formation, but antigens presented to the liver are less likely to do so and successful liver transplantation can be carried out in the pig without immunosuppression. Somewhere in this area may be the clue to the solution of the transplant problem. Haemodialysis-associated hepatitis is undoubtedly an iatrogenic disease, and this leads one to the perhaps paradoxical realisation that the results of medical research will not always be beneficial. Powerful therapeutic techniques are inevitably accompanied by the risk of serious side-effects and iatrogenic disease is likely to become a growing problem as scientific medicine advances. 
